Executive Vice President and President of Global Sales — Justin Keisel: The executive is on a temporary medical leave of absence with a designated interim leader, not a permanent departure or termination.

Results of Operations and Financial Condition. On August 10, 2026, Nu Skin Enterprises, Inc. (the “Company”) issued a press release announcing its financial results for the three- and six-month periods ended June 30, 2026, and certain other information. A copy of the press release is attached as Exhibit 99.1 to this report. The information furnished pursuant to this

The filing describes an update to the company's equity compensation plan, not a management change.

Executive Vice President and Chief Product Officer — Steven K. Hatchett: Resigned due to family health circumstances but remains as a strategic product advisor.

and Exhibit 99.1 shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and shall not be deemed to be incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act except as shall be expressly set forth by specific reference in such filing.

Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant. The information included in

Entry into a Material Definitive Agreement. On March 27, 2026 (the “Closing Date”), Nu Skin Enterprises, Inc. (the “Company”) entered into that certain Second Amendment and Restatement Agreement in connection with the Second Amended and Restated Credit Agreement (the “Credit Agreement”) by and among the Company, as Borrower, the Lenders from time to time party thereto and Bank of America, N.A., as Administrative Agent, which amends and restates the Company’s existing amended and restated cred…

Executive Vice President and Chief Financial Officer — James D. Thomas: James D. Thomas resigned to pursue an outside opportunity.

Executive Vice President, Chief Operating Officer and Chief Legal Officer — Chayce D. Clark: Mr. Chayce D. Clark was promoted to Executive Vice President, Chief Operating Officer and Chief Legal Officer.

Results of Operations and Financial Condition. On February 12, 2026, Nu Skin Enterprises, Inc. (the “Company”) issued a press release announcing its financial results for the three-month and annual periods ended December 31, 2025, and certain other information. A copy of the press release is attached as Exhibit 99.1 to this report. The information furnished pursuant to this

Results of Operations and Financial Condition. On November 6, 2025, Nu Skin Enterprises, Inc. (the “Company”) issued a press release announcing its financial results for the three- and nine-month periods ended September 30, 2025, and certain other information. A copy of the press release is attached as Exhibit 99.1 to this report. The information furnished pursuant to this

Results of Operations and Financial Condition. On August 7, 2025, Nu Skin Enterprises, Inc. (the “Company”) issued a press release announcing its financial results for the three- and six-month periods ended June 30, 2025, and certain other information. A copy of the press release is attached as Exhibit 99.1 to this report. The information furnished pursuant to this

The filing describes a stockholder-approved amendment to the company's incentive plan, not a management change.

and Exhibit 99.1 shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and shall not be deemed to be incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act except as shall be expressly set forth by specific reference in such filing.

Director — Zheqing (Simon) Shen: Mr. Shen decided not to stand for re-election due to other professional commitments.

Results of Operations and Financial Condition. On February 13, 2025, Nu Skin Enterprises, Inc. (the “Company”) issued a press release announcing its financial results for the three-month and annual periods ended December 31, 2024, and certain other information. A copy of the press release is attached as Exhibit 99.1 to this report. The information furnished pursuant to this

Results of Operations and Financial Condition. On January 13, 2025, Nu Skin Enterprises, Inc. issued a press release announcing preliminary information about its financial results for the three-month period ended December 31, 2024, and certain other information. A copy of the press release is attached as Exhibit 99.1 to this report. The information furnished pursuant to this

The Mavely Transaction closed on January 2, 2025. The Company is also filing herewith certain pro forma financial information related to the Mavely Transaction , which is attached hereto as Exhibit 99.2.

Entry into a Material Definitive Agreement. On January 2, 2025, Mavely Seller LLC (“ Seller ”), a Delaware limited liability company and subsidiary of Nu Skin Enterprises, Inc. (the “ Company ”), entered into a Unit Purchase Agreement (the “ Purchase Agreement ”) with Clout.io Holdings, Inc., a Delaware corporation (“ Purchaser ”), Mavrck LLC, a Delaware limited liability company and direct wholly-owned subsidiary of Purchaser (“ Mavrck ”), and Mavely LLC, a Delaware limited liability company…

Results of Operations and Financial Condition. On November 7, 2024, Nu Skin Enterprises, Inc. (the “Company”) issued a press release announcing its financial results for the three- and nine-month periods ended September 30, 2024, and certain other information. A copy of the press release is attached as Exhibit 99.1 to this report. The information furnished pursuant to this

Director — Mark A. Zorko: Appointment of a new director to the Board.

Results of Operations and Financial Condition. On August 8, 2024, Nu Skin Enterprises, Inc. (the “Company”) issued a press release announcing its financial results for the three- and six-month periods ended June 30, 2024, and certain other information. A copy of the press release is attached as Exhibit 99.1 to this report. The information furnished pursuant to this

Approval of a new compensation plan by stockholders.

and Exhibit 99.1 shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and shall not be deemed to be incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act except as shall be expressly set forth by specific reference in such filing.

Director — Andrew Lipman: Andrew Lipman has decided to retire from the Board of Directors and will not stand for re-election.